A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Clinical trial NCT01789736 · COMPLETED

Trial details

NCT number: NCT01789736
Sponsor: Aerie Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Open Angle Glaucoma Ocular Hypertension

Start date: 2013-02-01
Primary completion: 2013-06-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.